{"id":"W2168505126","doi":"10.1016/s0140-6736(09)60140-9","title":"Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial","year":2009,"lang":"en","type":"article","venue":"The Lancet","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":583,"is_retracted":false,"has_abstract":false,"ca_institutions":"Barrie Urology Group","funders":"","keywords":"Ustekinumab; Medicine; Psoriatic arthritis; Placebo; Psoriasis; Internal medicine; Clinical endpoint; Arthritis; Crossover study; Randomization; Secukinumab; Placebo-controlled study; Gastroenterology; Randomized controlled trial; Double blind; Dermatology; Rheumatoid arthritis; Pathology; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002900274,0.002862188,0.007676346,0.0007534157,0.0007309894,0.001502182,0.001232999,0.003668861,0.01131908],"category_scores_gemma":[0.003228874,0.001335159,0.002803428,0.0009845546,0.002042498,0.001816746,0.0005717512,0.003754406,0.002128834],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009366602,"about_ca_system_score_gemma":0.00113711,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001805948,"about_ca_topic_score_gemma":0.00248087,"domain_scores_codex":[0.9985622,0.0006900855,0.000132101,0.0002940422,0.0001199316,0.0002015743],"domain_scores_gemma":[0.9988703,0.0004230783,0.0002071549,0.0001120756,0.00008623537,0.0003011541],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9936182,0.0008502072,0.00007691907,0.0006791728,0.0005728384,0.00001430705,0.00001723306,0.00005659624,0.0006668435,0.00006262572,0.0003319222,0.003053093],"study_design_scores_gemma":[0.9917541,0.007363639,0.0002165551,0.00001849556,0.0002769999,0.000008911614,0.000006166869,0.00005419261,0.00006945772,0.00004895605,0.0001766408,0.00000591476],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9234766,0.04078884,0.003362844,0.002252634,0.005418472,0.01331055,0.004502715,0.000591957,0.006295281],"genre_scores_gemma":[0.9508914,0.01757688,0.003615808,0.003011473,0.002020909,0.01135852,0.002188331,0.00008915995,0.009247556],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01131908,"threshold_uncertainty_score":0.03786606,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05254111303542622,"score_gpt":0.354957799294689,"score_spread":0.3024166862592628,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}